Muscle loss during GLP-1 treatment has received increasing attention — particularly after a study suggested that some of the weight lost on semaglutide included lean mass, not just fat. This is worth understanding clearly, without either dismissing it or overstating it. The truth is nuanced, practical, and actionable.
The Science: What Actually Happens
Any significant caloric deficit — from any cause — results in some combination of fat loss and lean mass loss. This is well-established in the research literature. The ratio of fat to muscle lost depends on: how large the caloric deficit is, how much protein you eat, and whether you are performing resistance training.
GLP-1 medications can reduce appetite and food intake. Reduced intake can make it harder to meet protein and other nutritional needs; the size of this effect varies between patients.
Research published in Diabetes, Obesity and Metabolism reported that approximately 75% of weight lost was fat and 25% was lean mass in both the tirzepatide and placebo groups of a 160-participant SURMOUNT-1 substudy. This does not show superior muscle preservation with tirzepatide. DXA measures lean tissue, not muscle strength, and lean mass includes more than skeletal muscle.
In practical terms: GLP-1 medications do not uniquely target muscle. But they do create the conditions (large caloric deficit, reduced appetite making protein targets harder to hit) that, without intervention, lead to more muscle loss than necessary.
The Two-Part Solution
Ask your provider or dietitian to set a protein target based on your health, nutritional intake and activity.
2–4 sessions per week of progressive resistance exercise directly stimulates muscle protein synthesis — the body's muscle-building and preserving mechanism.
The nutritional advisory published in Obesity emphasizes adequate protein together with resistance exercise to support muscle health. It does not establish that these steps preserve nearly all lean mass in every patient.
Why This Matters for Long-Term Results
The weight loss you achieve on GLP-1 medications is only as durable as the metabolic foundation you build while losing. If you lose 40 pounds and 10 of those pounds were muscle, your resting metabolic rate is now lower than it would have been had you lost only fat. When you eventually reduce or stop medication, you are burning fewer calories at rest — making weight regain easier and weight maintenance harder.
Preserving strength and function is an important care goal. Discuss nutrition, exercise and any changes in strength with your provider; muscle preservation alone does not ensure long-term weight maintenance.
Action Steps
- Ask your provider or dietitian for a protein target that accounts for your health and nutritional needs.
- Discuss a safe starting exercise plan. Delay strenuous activity when you are unwell, dehydrated or dizzy and ask your provider for guidance.
- Eat protein first at every meal. When appetite is limited, fill up on the most important macronutrient first.
- Discuss your goals with your provider. Your care plan should explicitly include muscle preservation strategies.
- Track body composition, not just weight. Ask your provider about body composition assessment options.